{"id":"NCT02514772","sponsor":"Sandoz","briefTitle":"GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®","officialTitle":"A Randomized, Double- Blind, Controlled, Parallel-group, Multicenter Study to Assess the Safety and Immunogenicity of Transitioning to GP2013 or Re-treatment With Rituxan® or MabThera® in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-07","primaryCompletion":"2016-07","completion":"2016-10","firstPosted":"2015-08-04","resultsPosted":"2017-12-28","lastUpdate":"2017-12-28"},"enrollment":107,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"BIOLOGICAL","name":"GP2013 - A Proposed biosimilar rituximab","otherNames":[]},{"type":"BIOLOGICAL","name":"Originator rituximab - Rituxan ® or MabThera ®","otherNames":[]}],"arms":[{"label":"GP2013 - proposed biosimilar rituximab","type":"EXPERIMENTAL"},{"label":"Originator rituximab - Rituxan ® or MabThera ®","type":"ACTIVE_COMPARATOR"}],"summary":"The study objective is to identify potential safety risks of the transition from US-licensed Rituxan® or EU-approved MabThera® to GP2013 (proposed biosimilar product) as compared to continuous treatment with the originator product in terms of general safety and immunogenicity.","primaryOutcome":{"measure":"Number of Patients Experiencing Anaphylactic Reactions","timeFrame":"Within 24 hours of each study drug infusion: on Day 1 and Day 14","effectByArm":[{"arm":"GP2013","deltaMin":0,"sd":null},{"arm":"Rituxan® / MabThera®","deltaMin":1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":65,"countries":["United States","Germany","Hungary","Poland"]},"refs":{"pmids":["30295429"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":53},"commonTop":["Bronchitis","Upper respiratory tract infection","Rheumatoid arthritis","Headache","Nausea"]}}